The presence of CD36+ metastasis-initiating cells correlated with a poor prognosis for numerous carcinomas, including breast carcinoma, and the inhibition of CD36 impaired the metastasis of breast tumor cells [111]. This evidence concerns the gene CD36 and carcinoma.